Publications: Dr Anna Surace
Çubuk C, Lau R, Cutillas P, Rajeeve V, John CR, Surace AEA, Hands R, Fossati-Jimack L et al.
(
2024
)
.
Phosphoproteomic profiling of early rheumatoid arthritis synovium reveals active signalling pathways and differentiates inflammatory pathotypes
.
Arthritis Research & Therapy
vol.
26
,
(
1
)
Lau R, Cubuk C, Rajeeve V, Cutillas P, Hands R, Fossati-Jimack L, Surace A, Lewis M et al.
(
2024
)
.
OP0218 SYNOVIAL PHOSPHOPROTEOME ANALYSIS OF LATE-STAGE RHEUMATOID ARTHRITIS PATIENTS (R4RA TRIAL) IDENTIFIES SIGNALLING PATHWAYS ASSOCIATED WITH PATHOTYPE AND RESPONSE TO RITUXIMAB AND TOCILIZUMAB
.
Conference:
Scientific Abstracts12
-
12
.
Surace A, Overend L, Sciacca E, Fossati-Jimack L, Jaworska E, Pontarini E, Bashford-Rogers RJM, Pitzalis C et al.
(
2024
)
.
OP0242 SYNOVIAL TISSUE AND BLOOD DEEP B/T CELL PHENOTYPING EXPLAINS RESPONSE MECHANISMS TO RITUXIMAB IN RHEUMATOID ARTHRITIS IN R4RA
.
Conference:
Scientific Abstracts13.2
-
1314
.
Sciacca E, Surace AEA, Alaimo S, Pulvirenti A, Rivellese F, Goldmann K, Ferro A, Latora V et al.
(
2022
)
.
Network analysis of synovial RNA sequencing identifies gene-gene interactions predictive of response in rheumatoid arthritis
.
Arthritis Research & Therapy
vol.
24
,
(
1
)
Surace A, Sciacca E, Goldmann K, Rivellese F, Cubuk C, Giorli G, Fossati-Jimack L, Ahmed M et al.
(
2022
)
.
OP0077 SYNOVIAL RNA-SEQ ANALYSIS OF THE R4RA TRIAL IDENTIFIES SIGNATURES OF TREATMENT RESISTANCE AND REFRACTORY STATE IN RHEUMATOID ARTHRITIS
.
Annals of the Rheumatic Diseases
vol.
81
,
(
Suppl 1
)
52.2
-
5253
.
Rivellese F, Cubuk C, Surace A, Goldmann K, Sciacca E, Giorli G, Nerviani A, Fossati-Jimack L et al.
(
2022
)
.
OP0085 CELL LINEAGE-SPECIFIC TRANSCRIPT DECONVOLUTION OF SYNOVIAL BIOPSIES FROM THE R4RA TRIAL IDENTIFIES CELL POPULATIONS ASSOCIATED WITH RESPONSE TO RITUXIMAB AND TOCILIZUMAB
.
Annals of the Rheumatic Diseases
vol.
81
,
(
Suppl 1
)
56.2
-
5657
.
Rivellese F, Surace AEA, Goldmann K, Sciacca E, Çubuk C, Giorli G, John CR, Nerviani A et al.
(
2022
)
.
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
.
Nature Medicine
vol.
28
,
(
6
)
1256
-
1268
.
Rivellese F, Pontarini E, Cubuk C, Nerviani A, Fossati-Jimack L, Surace A, Sciacca E, Goldmann K et al.
(
2022
)
.
Module Signatures of Synovial Single-cell States Identify Disease Phenotypes in Early Treatment-naive Rheumatoid Arthritis
.
ARTHRITIS & RHEUMATOLOGY
.
vol.
74
,
3345
-
3347
.
Hofmann SR, Carlsson E, Kapplusch F, Carvalho AL, Liloglou T, Schulze F, Abraham S, Northey S et al.
(
2021
)
.
Cyclic AMP Response Element Modulator-α Suppresses PD-1 Expression and Promotes Effector CD4+ T Cells in Psoriasis
.
The Journal of Immunology
vol.
207
,
(
1
)
55
-
64
.
Sciacca E, Surace A, Lewis M, Alaimo S, Latora V, Rivellese F, Pulvirenti A, Ferro A et al.
(
2020
)
.
Novel Network Tool Highlights Key Features Associated with Disease Pathotypes and Response to Treatment in Early Rheumatoid Arthritis
.
ARTHRITIS & RHEUMATOLOGY
.
Conference:
ACR Convergence 2020
vol.
72
,
Hofmann S, Kapplusch F, Abraham S, Northey S, Russ S, Schulze F, Surace A, Hedrich C
(
2020
)
.
cAMP Response Element Modulator (CREM)α Promotes PD-1-effector CD4+T Cells in Psoriasis and Psoriatic Arthritis
.
ARTHRITIS & RHEUMATOLOGY
.
vol.
72
,
King C, Surace AE, Jeffers G, Hawcutt D, Sinha I
(
2019
)
.
The effects of ambient air pollution on the risk of hospitalisation with acute respiratory illnesses in children: an overview of systematic reviews
.
Conference:
Occupational and environmental health
Surace AEA, Hedrich CM
(
2019
)
.
The Role of Epigenetics in Autoimmune/Inflammatory Disease
.
Frontiers in Immunology
vol.
10
,
Neame MT, Chacko J, Surace AE, Sinha IP, Hawcutt DB
(
2019
)
.
A systematic review of the effects of implementing clinical pathways supported by health information technologies
.
Journal of the American Medical Informatics Association
vol.
26
,
(
4
)
356
-
363
.
Ramanathan K, Glaser A, Lythgoe H, Ong J, Beresford MW, Midgley A, Wright HL
(
2017
)
.
Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes
.
Rheumatology
vol.
57
,
(
3
)
488
-
498
.